Abstract
Available anti-obesity pharmacotherapy options remain very limited. The development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake, by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacological treatment options.
Keywords: Obesity, drug treatment, orlistat, sibutramine, rimonabant, leptin, ghrelin
Mini-Reviews in Medicinal Chemistry
Title: Drug Treatment of Obesity: Established and Emerging Therapies
Volume: 9 Issue: 6
Author(s): M. Luisa Isidro and Fernando Cordido
Affiliation:
Keywords: Obesity, drug treatment, orlistat, sibutramine, rimonabant, leptin, ghrelin
Abstract: Available anti-obesity pharmacotherapy options remain very limited. The development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake, by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacological treatment options.
Export Options
About this article
Cite this article as:
Isidro Luisa M. and Cordido Fernando, Drug Treatment of Obesity: Established and Emerging Therapies, Mini-Reviews in Medicinal Chemistry 2009; 9 (6) . https://dx.doi.org/10.2174/138955709788452739
DOI https://dx.doi.org/10.2174/138955709788452739 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CD26 Inhibition Enhances Perfusion Recovery in ApoE-/-Mice
Current Vascular Pharmacology Massively Parallel Screening of the Receptorome
Combinatorial Chemistry & High Throughput Screening The Genetics of Small-Vessel Disease
Current Medicinal Chemistry Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Current Cardiology Reviews The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry New Treatments for Emerging Cystic Fibrosis Pathogens other than Pseudomonas
Current Pharmaceutical Design Effect of Alpha-lipoic Acid Supplementation on Trace Element Levels in Serum and in Postmitotic Tissue in Aged Rats
Medicinal Chemistry Aerosol Devices and Asthma Therapy
Current Drug Delivery Targeting Analysis of Gallic Acid and Bioactive Components in Xuebijing Injection with Loop-based Heart-cutting Two-dimensional Liquid Chromatography
Current Pharmaceutical Analysis Catheter Ablation of Lone Atrial Fibrillation
Current Pharmaceutical Design Ventilation Therapy for Patients Suffering from Obstructive Lung Diseases
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials The Role of Oxidative Stress in the Pathogenesis of Type 2 Diabetes Mellitus Micro- and Macrovascular Complications: Avenues for a Mechanistic-Based Therapeutic Approach
Current Diabetes Reviews Recent Advances in Transcatheter Heart Valve Replacement: A Review on Aortic and Mitral Implantation
Recent Patents on Biomedical Engineering (Discontinued) Bivalirudin or Heparin Treatment During Transcatheter Valve Interventions: Where are we Now?
Current Pharmaceutical Design Coronary CT and the Coronary Calcium Score, the Future of ED Risk Stratification?
Current Cardiology Reviews Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women
Current Vascular Pharmacology The Application of NMR Spectroscopy for the Study of Heart Failure
Current Pharmaceutical Design Catastrophic Antiphospholipid Syndrome: Lessons from the “CAPS Registry”
Current Rheumatology Reviews Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design